ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Seven Divisions Proposed, Separating Intramural, Extramural Programs

August 11, 1995

In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale

September 28, 1990

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985